Retatrutide 30 mg

RT-2026-063Lot ALR209-RT30Analyzed November 3, 2026

Timeline

Ordered

October 14, 2026

Received

November 2, 2026

Analyzed

November 3, 2026

Sample

Name

Retatrutide 30 mg

Expected

Retatrutide

Amount

1 vial, lyophilized powder

Testing

Client

Alpha Lab Research

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

35.16mg

Label claim: 30 mg

Purity, how clean it is

99.3%

by HPLC-UV peak area, system peaks excluded

Chromatogram

HPLC-UV

17.93 min, Retatrutide, 99.3%

Analyst Comments

White lyophilized powder, black-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: November 3, 2026

Verification Code

RT-8KUI-R75B

Verify at purilab.org/verify/RT-8KUI-R75B

Scan to Verify

RT-8KUI-R75B

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1